IGF1 and neoplasm: Metformin’s efficacy in reducing IGF-1 levels and tumor burden is particularly notable in patients on a high-energy diet, suggesting a greater effect in metabolically disrupted environments, which could be the reason why we did not reach the IC50 on cell lines, since the culture medium of the cells has glucose.